Ever wonder how pharma companies make their drugs? It’s a lot different now than it was a few decades ago. Modern technology and some innovative thinking are making traditional enzyme inhibitors not the only thing on the market. So come join us, and learn about molecular glues, multifunctional antibodies, and more. Discover what’s happening at the new frontier of proximity-based therapeutics. And also learn about how current strategies such as DNA-encoded libraries, molecular docking, and machine learning are being used to accelerate the development of therapeutics.